| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 42.1% | 8/19 |
| Female | 57.9% | 11/19 |
| Indifferent | 0% | 0/19 |
| Unknown | 0% | 0/19 |
| General | ||
| 22.2% | 2/9 | |
| 23.5% | 4/17 | |
| 12.5% | 1/8 | |
| 27.8% | 5/18 | |
| 41.2% | 7/17 | |
| 5.3% | 1/19 | |
| 88.9% | 16/18 | |
| 61.1% | 11/18 | |
| 70.6% | 12/17 | |
| 78.6% | 11/14 | |
| Neurology | ||
| 68.4% | 13/19 | |
| 57.9% | 11/19 | |
| 36.8% | 7/19 | |
| Facial abnormalities | ||
| 78.9% | 15/19 | |
| 73.7% | 14/19 | |
| 63.2% | 12/19 | |
| 84.2% | 16/19 | |
| Visual and hearing impairments | ||
| 10.5% | 2/19 | |
| 26.3% | 5/19 | |
| Heart | ||
| 26.3% | 5/19 | |
| Pulmonary | ||
| 33.3% | 1/3 | |
| Gastrointestinal | ||
| 68.4% | 13/19 | |
| Urogenital | ||
| 21.1% | 4/19 | |
| Skeleton | ||
| 68.4% | 13/19 | |
| Skin / Hair / Nails | ||
| 47.4% | 9/19 | |
| Endocrine / Immunological / Metabolic | ||
| 36.8% | 7/19 | |
| 5.3% | 1/19 | |
| 10.5% | 2/19 | |
| Neoplasia | ||
| 5.3% | 1/19 | |
| Inheritance | ||
| 100% | 18/18 | |
YY1